Suppr超能文献

微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。

Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.

作者信息

Witschi C, Doelker E

机构信息

School of Pharmacy, University of Geneva, Switzerland.

出版信息

J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.

Abstract

Three methods were used, namely spray drying, w/o/w solvent evaporation and the aerosol solvent extraction system (ASES), for the preparation of microparticles having the same size range, to study the influence of the preparation method on polymer degradation in vitro (PBS, 37 degrees C, one month). The following five polymers of the biodegradable poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) group were selected: L-PLA, MW 81 200; DL-PLGA 75:25, MW 64-300; DL-PLGA 50:50 MW 52 600; DL-PLGA 50:50 MW 14 500, AND DL-PLGA 50:50, MW 3400, to prepare drug-free and drug-loaded microparticles. Tetracosactide was selected as model peptide. When microparticles were prepared by solvent evaporation, the mean diameter and, more markedly, the drug encapsulation efficiency tended to decrease when decreasing the molecular weight and increasing the proportion of glycolic acid in the polymer. In contrast, no direct influence of the polymer nature on these parameters was observed in spray dried microparticles. Polymer degradation was heterogenous in L-PLA and DL-PLGA 75:25 microparticles and was not influenced by the presence of the drug at a nominal loading of 1% (w/w), when prepared by the three methods (note that with ASES, only L-PLA could be used for microencapsulation). In batches made of DL-PLGA 50:50 MW 52 600, the degradation rate decreased slightly when increasing the drug loading. Only in the case of DL-PLGA 50:50 MW 14 500, the polymer degradation rate for spray dried microparticles was higher compared to that for microparticles prepared by the w/o/w solvent evaporation method. Generally, the degradation rates of the different microparticles followed the expected order: L-PLA<DL-PLGA 75:50<DL-PLGA 50:50(Mw 52 600)<DLPLGA 50:50 (a mixture of MW 52 600 and MW 3400). Polymer degradation was homogenous in DL-PLGA 50:50 microparticles. Decreasing the molecular weight of DL-PLGA 50:50 from 52 600 to 14 500 did not result in accelerated polymer degradation.

摘要

采用了三种方法,即喷雾干燥法、水包油包水溶剂蒸发法和气溶胶溶剂萃取系统(ASES),来制备尺寸范围相同的微粒,以研究制备方法对聚合物体外降解(在37℃的PBS中,为期一个月)的影响。从可生物降解的聚乳酸(PLA)和聚乳酸-乙醇酸共聚物(PLGA)组中选择了以下五种聚合物:L-PLA,分子量81200;DL-PLGA 75:25,分子量64 - 300;DL-PLGA 50:50,分子量52600;DL-PLGA 50:50,分子量14500;以及DL-PLGA 50:50,分子量3400,用于制备不含药物和载药的微粒。选择替可克肽作为模型肽。当通过溶剂蒸发法制备微粒时,随着聚合物分子量的降低和乙醇酸比例的增加,平均直径,更明显的是药物包封效率往往会降低。相比之下,在喷雾干燥的微粒中未观察到聚合物性质对这些参数有直接影响。在L-PLA和DL-PLGA 75:25微粒中,聚合物降解是不均匀的,并且在通过三种方法制备时(注意,对于ASES,仅L-PLA可用于微囊化),在标称载药量为1%(w/w)时,药物的存在对其没有影响。在由DL-PLGA 50:50(分子量52600)制成的批次中,随着药物载量的增加,降解速率略有降低。仅在DL-PLGA 50:50(分子量14500)的情况下,喷雾干燥微粒的聚合物降解速率高于通过水包油包水溶剂蒸发法制备的微粒。一般来说,不同微粒的降解速率遵循预期顺序:L-PLA<DL-PLGA 75:50<DL-PLGA 50:50(分子量52600)<DLPLGA 50:50(分子量52600和分子量3400的混合物)。DL-PLGA 50:50微粒中的聚合物降解是均匀的。将DL-PLGA 50:50的分子量从52600降低到14500并不会导致聚合物降解加速。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验